Showing results (1441-1450 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|February 11, 2025
Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomesShuai Xu, Chao Han, Jian Zhou, et al.Cancer Immunology, Immunotherapy : CII|February 4, 2025
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinomaMaki Todo, Yodo Gatate, Shintaro Nakano, et al.Cancer Immunology, Immunotherapy : CII|February 4, 2025
PSMA antibody, humanized PSMA.CAR10.3, or Cetuximab increases prostate cancer localization of NF-κB p50-deficient immature myeloid cells (p50-IMC) and phagocytosis by their macrophage progenyMohammad A Alzubi, Theresa Barberi, Alan D FriedmanCancer Immunology, Immunotherapy : CII|February 1, 2025
CD155 promotes the progression of colorectal cancer by restraining CD8+ T cells via the PI3K/AKT/NF-κB pathwayRongpu Liang, Liting Liu, Dongbing Ding, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2025
Effect of RAS mutations and related immune characteristics on the prognosis of patients with MSI-H/dMMR colorectal cancerYupeng Jiang, Yuyao Liu, Hong Huang, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2025
Blood-based prognostic scores and early dynamics under immunotherapy to select patients with metastatic solid tumors for continuing immune check-point inhibition: a prospective longitudinal studyJavier García-Corbacho, Alberto Indacochea, Iván Victoria, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2025
Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.Cancer Immunology, Immunotherapy : CII|February 1, 2025
Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort studyHongjie Cai, Song Chen, Shuangyan Tang, et al.Cancer Immunology, Immunotherapy : CII|March 15, 2025
Navigating TAM receptor dynamics in tumour immunotherapyJihao Yang, Guanmin Chen, Rui Wang, et al.Cancer Immunology, Immunotherapy : CII|February 25, 2025
Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancerGaofei Yin, Nuan Li, Xiaohong Chen, et al.Pageof 651